Zusammenfassung
Patienten mit kardiogenem Schock stellen aufgrund der kardiorespiratorischen Instabilität – neben den Herausforderungen der Therapie der Grunderkrankung – zusätzlich hohe Anforderungen an den Behandler, wenn eine Analgosedierung und Beatmung notwendig werden. Die genutzten Substanzen beeinflussen ihrerseits häufig die Hämodynamik und Oxygenierung. Der Artikel bietet eine Übersicht der gängig verfügbaren Substanzen unter Berücksichtigung der speziellen Anforderungen dieser Patienten, der Überwachung der Sedierung und der Möglichkeiten zur Optimierung der Analgosedierung.
Abstract
Patients with cardiogenic shock pose a challenge to physicians due to cardiorespiratory instability in addition to the underlying medical condition. If analgosedation and ventilation are indicated, commonly administered drugs themselves often influence hemodynamics and oxygenation. The present article provides an overview of the available substances with consideration of the patientsʼ condition, then monitoring and optimization of analgosedation.
Literatur
Bernhard M, Bein B, Böttiger BW, Bohn A, Fischer M, Gräsner JT, Hinkelbein J, Kill C, Lott C, Popp E, Roessler M, Schaumberg A, Wenzel V, Hossfeld B (2015) Handlungsempfehlung zur prähospitalen Notfallnarkose beim Erwachsenen: Arbeitsgruppe „Prähospitale Notfallnarkose“ des Wissenschaftlichen Arbeitskreises Notfallmedizin der Deutschen Gesellschaft für Anästhesiologie und Intensivmedizin. Notfall Rettungsmedizin 18:395–412. doi:10.1007/s10049-015-0041-9
Bignami E, Biondi-Zoccai G, Landoni G, Fochi O, Testa V, Sheiban I, Giunta F, Zangrillo A (2009) Volatile anesthetics reduce mortality in cardiac surgery. J Cardiothorac Vasc Anesth 23:594–599. doi:10.1053/j.jvca.2009.01.022
Brusco L (2002) Choice of sedation for critically Ill patients A Rational. Adv Stud Med 2:343–349
Culp KE, Augoustides JG, Ochroch AE, Milas BL (2004) Clinical management of cardiogenic shock associated with prolonged propofol infusion. Anesth Analg 99:221–226. doi:10.1213/01.ANE.0000117285.12600.C1
Deng J, Lei C, Chen Y, Fang Z, Yang Q, Zhang H, Cai M, Shi L, Dong H, Xiong L (2014) Neuroprotective gases – Fantasy or reality for clinical use? Prog Neurobiol 115:210–245. doi:10.1016/j.pneurobio.2014.01.001
Elliott P, O’Hare R, Bill KM, Phillips AS, Gibson FM, Mirakhur RK (2000) Severe cardiovascular depression with remifentanil. Anesth Analg 91:58–61. doi:10.1213/00000539-200007000-00011
Ely EW, Truman B, Shintani A, Thomason JWW, Wheeler AP, Gordon S, Francis J, Speroff T, Gautam S, Margolin R, Sessler CN, Dittus RS, Bernard GR (2003) Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA 289:2983–2991. doi:10.1001/jama.289.22.2983
Ethuin F, Boudaoud S, Leblanc I, Troje C, Marie O, Levron J-C, Le Moing J-P, Assoune P, Eurin B, Jacob L (2003) Pharmacokinetics of long-term sufentanil infusion for sedation in ICU patients. Intensive Care Med 29:1916–1920. doi:10.1007/s00134-003-1920-y
Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, Davila-Roman VG, Gerhard-Herman MD, Holly TA, Kane GC, Marine JE, Nelson MT, Spencer CC, Thompson A, Ting HH, Uretsky BF, Wijeysundera DN (2014) 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 130:2215–2245. doi:10.1161/CIR.0000000000000105
Kugler J, Schwab RS (1981) Elektroenzephalographie in Klinik und Praxis: eine Einführung, 3. überarb. und erw. Aufl. Thieme, Stuttgart
Landoni G, Biondi-Zoccai GGL, Zangrillo A, Bignami E, D’Avolio S, Marchetti C, Calabrò MG, Fochi O, Guarracino F, Tritapepe L, De Hert S, Torri G (2007) Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomized clinical trials. J Cardiothorac Vasc Anesth 21:502–511. doi:10.1053/j.jvca.2007.02.013
Landoni G, Augoustides JG, Guarracino F, Santini F, Ponschab M, Pasero D, Rodseth RN, Biondi-Zoccai G, Silvay G, Salvi L, Camporesi E, Comis M, Conte M, Bevilacqua S, Cabrini L, Cariello C, Caramelli F, De Santis V, Del Sarto P, Dini D, Forti A, Galdieri N, Giordano G, Gottin L, Greco M, Maglioni E, Mantovani L, Manzato A, Meli M, Paternoster G, Pittarello D, Rana KN, Ruggeri L, Salandin V, Sangalli F, Zambon M, Zucchetti M, Bignami E, Alfieri O, Zangrillo A (2011) Mortality reduction in cardiac anesthesia and intensive care: results of the first International Consensus Conference. Acta Anaesthesiol Scand 55:259–266. doi:10.1111/j.1399–6576.2010.02381.x
Lin YY, He B, Chen J, Wang ZN (2012) Can dexmedetomidine be a safe and efficacious sedative agent in post-cardiac surgery patients? A meta-analysis. Crit Care 16:R169. doi:10.1186/cc11646
Lison S, Schill M, Conzen P (2007) Fast-track cardiac anesthesia: efficacy and safety of remifentanil versus sufentanil. J Cardiothorac Vasc Anesth 21:35–40. doi:10.1053/j.jvca.2006.03.011
Lotz C, Kehl F (2015) Volatile anesthetic-induced cardiac protection: molecular mechanisms, clinical aspects, and interactions with nonvolatile agents. J Cardiothorac Vasc Anesth 29:749–760. doi:10.1053/j.jvca.2014.11.012
Michelsen LG (2000) Hemodynamic effects of remifentanil in patients undergoing cardiac surgery. Anesth Analg 91:1563. doi:10.1097/00000539-200012000-00059
Schultz B, Grouven U, Schultz A (2002) Automatic classification algorithms of the EEG monitor Narcotrend for routinely recorded EEG data from general anaesthesia: a validation study. Biomed Tech (Berl) 47:9–13
Schultz B, Kreuer S, Wilhelm W, Grouven U, Schultz A (2003) [The Narcotrend monitor. Development and interpretation algorithms]. Anaesthesist 52:1143–1148. doi:10.1007/s00101-003-0603-y
Schultz A, Grouven U, Beger FA, Schultz B (2004) The Narcotrend Index: classification algorithm, correlation with propofol effect-site concentrations, and comparison with spectral parameters/Der Narcotrend-Index: klassifikationsalgorithmus, Korrelation mit Propofol-Effekt-Site-Konzentrationen und Vergleich mit Spektralparametern. Biomed Tech Eng 49:38–42
Sessler CN, Gosnell MS, Grap MJ, Brophy GM, O’Neal PV, Keane KA, Tesoro EP, Elswick RK (2012) The Richmond Agitation–Sedation Scale. Am J Respir Crit Care Med. doi:10.1164/rccm.2107138
Sichrovsky TC, Mittal S, Steinberg JS (2008) Dexmedetomidine sedation leading to refractory cardiogenic shock. Anesth Analg 106:1784–1786. doi:10.1213/ane.0b013e318172fafc
Stollings JL, Diedrich DA, Oyen LJ, Brown DR (2014) Rapid-sequence intubation a review of the process and considerations when choosing medications. Ann Pharmacother 48:62–76. doi:10.1177/1060028013510488
Tempia A, Olivei MC, Calza E, Lambert H, Scotti L, Orlando E, Livigni S, Guglielmotti E (2003) The anesthetic conserving device compared with conventional circle system used under different flow conditions for inhaled anesthesia. Anesth Analg 96:1056–1061. doi:10.1213/01.ANE.0000050558.89090.95
Twersky RS, Jamerson B, Warner DS, Fleisher LA, Hogue S (2001) Hemodynamics and emergence profile of remifentanil versus fentanyl prospectively compared in a large population of surgical patients. J Clin Anesth 13:407–416. doi:10.1016/S0952-8180(01)00292-6
Vender JS, Szokol JW, Murphy GS, Nitsun M (2004) Sedation, analgesia, and neuromuscular blockade in sepsis: an evidence-based review. Crit Care Med 32:S554–S561. doi:10.1097/01.CCM.0000145907.86298.12
Warltier DC, Pagel PS, Kersten JR (2000) Approaches to the prevention of perioperative myocardial ischemia. J Am Soc Anesthesiol 92:253–253
Werdan K, Ruß M, Buerke M, Engelmann L, Ferrari M, Friedrich I, Geppert A, Graf J, Hindricks G, Janssens U, Pieske B, Prondzinsky R, Reith S, Trappe H, Zehender M, Zerkowski H, Zeymer U, Adams H, Briegel J, Delle-Karth G, Schöndube F, Schwaab B, Bode C, Christoph A, Erbel R, Fuhrmann J, Strasser R, Figulla H, Görge G, Schmitt D, Schuler G, Silber R, Tebbe U, Zwißler B (2011) Deutsch-österreichische S3-Leitlinie „Infarktbedingter kardiogener Schock – Diagnose, Monitoring und Therapie“. Intensivmed Notfallmedizin 48:291–344. doi:10.1007/s00390-011-0284-8
Zuo Z (2012) Are volatile anesthetics neuroprotective or neurotoxic? Med Gas Res 2:10. doi:10.1186/2045-9912-2-10
Zwerus R, Absalom A (2015) Update on anesthetic neuroprotection. Curr Opin Anaesthesiol 28:424–430. doi:10.1097/ACO.0000000000000212
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
H. Lemm, M. Janusch und M. Buerke geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Additional information
Redaktion
S. Reith, Aachen
H. Hetz, Wien
Rights and permissions
About this article
Cite this article
Lemm, H., Janusch, M. & Buerke, M. Spezielle Aspekte der Analgosedierung bei Patienten mit kardiogenem Schock. Med Klin Intensivmed Notfmed 111, 22–28 (2016). https://doi.org/10.1007/s00063-015-0131-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00063-015-0131-y